Colon Flashcards
intussusception
in adults, managed operatively
Patient with diarrhea
lymphocytic colitis
1st line therapy- budesonide 9mg/day for 8 weeks, then 6mg for 2 weeks, then 3mg for 2 weeks
for recurrence give 6mg taper over 6 months
Collagenous colitis
1st line therapy- budesonide 9mg/day for 8 weeks, then 6mg for 2 weeks, then 3mg for 2 weeks
for recurrence give 6mg taper over 6 months
Thumbprinting of the bowel
concerning for severe colitis
ischemic colitis, UC, c. diff, etc
Single stripe sign of ischemic colitis
Sigmoid volvulus
Coffee bean sign
volvulus
Whirl sign
Cecal volvulus
cecal volvulus
intussusception
target sign
intussusception
target sign or bulls eye
what is the anorectal inhibitory reflex?
when stool reaches rectum,
involuntary relaxation of internal anal sphincter
voluntary contraction of external anal sphincter to maintain continence
RAIR is absent in hirschprung’s
What are the mechanism of actions for and doses in CIC and IBS-C?
-linaclotide
-plecanitide
-lubiprostone
-prucalopride
-linaclotide - increase Cl secretion via GC-C/ CFTR (max 145microgm in CIC, 290microgm in IBS-C)
-plecanitide- CFTR pathway - 3mg daily
-lubiprostone - increase CL secretion via CCL2 pathway -24microgm in CIC vs 8microgm in IBS-c
-prucalopride - 5HT agonist 1-2mg daily in CIC, not approved for IBS-C
Pathology seen in GVHD
epithelial cell apoptosis with apoptotic bodies, as well as loss of crypts and crypt necrosis
SMAD4
CHD1
CHEK2
SMAD4 - juvenile polyposis syndrome; CRC, stomach
CHD1- diffuse gastric cancer, lobular breast cancer
CHEK2- breast cancer, low risk of CRC